Juneko Grilley-Olson

Conception and design: Ian E. Krop, Juneko E. Grilley-Olson, Josh D. Lauring, Edith P. Mitchell, Robert J. Gray, Lisa M. McShane, Larry V. Rubinstein, David Patton, P. Mickey Williams, Stanley R. Hamilton, Barbara A. Conley, Carlos L. Arteaga, Peter J. O'Dwyer, Alice P. Chen, Keith T. Flaherty Financial support: David Patton Administrative support: David Patton, Carlos L. Arteaga, Lyndsay N. Harris Collection and assembly of data: Ian E. Krop, Opeyemi A. Jegede, Juneko E. Grilley-Olson, James A. Zwiebel, Robert J.

Soft tissue sarcomas (STS) are a heterogeneous group of mesenchymal malignancies diagnosed in approximately 13,000 patients and resulting in 5,000 deaths in the United States annually.1 With over 50 histologic subtypes,2 each harboring unique molecular drivers and biologic behavior, the National Comprehensive Cancer Network guidelines recommend a multidisciplinary team experienced in caring for these rare cancers.3 Approximately 90% of patients with STS present with localized disease,...

This is really funny and helpful, too- I remember my fist ASCO Meeting was 1991 ..... Petra